| Name | ethyl 2-(6-oxo-1H-pyrimidin-5-yl)acetate |
|---|---|
| Synonyms |
4-Hydroxy-5-ethoxycarbonylmethyl-pyrimidin
4-Hydroxy-pyrimidyl-5-essigsaeure-ethylester 2-(6-oxo-1H-pyrimidin-5-yl)acetic acid ethyl ester |
| Density | 1.268g/cm3 |
|---|---|
| Boiling Point | 314.46ºC at 760 mmHg |
| Molecular Formula | C8H10N2O3 |
| Molecular Weight | 182.17700 |
| Flash Point | 143.981ºC |
| Exact Mass | 182.06900 |
| PSA | 72.31000 |
| LogP | 0.28780 |
| Index of Refraction | 1.538 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933599090 |
|
~39%
6214-46-6 |
| Literature: CANCER THERAPEUTICS CRC PTY LTD; DEVLIN, Mark Graeme; STREET, Ian Philip; TONG, Warwick Bonner Patent: WO2014/27199 A1, 2014 ; Location in patent: Page/Page column 133 ; |
|
~%
6214-46-6 |
| Literature: WO2012/110773 A1, ; WO 2012/110773 A1 |
|
~%
6214-46-6 |
| Literature: WO2012/110773 A1, ; WO 2012/110773 A1 |
| Precursor 3 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |